Showing results (21-30 of 23) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Neurology and Therapy|May 16, 2020
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS StudiesAntonio Bertolotto, Rafael Arroyo, Elisabeth G Celius, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 9, 2023
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studiesColin M Dayan, Beatriz Lecumberri, Ilaria Muller, et al.CNS Drugs|July 26, 2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyTjalf Ziemssen, Ann D Bass, Regina Berkovich, et al.Pageof 3